Search Results 8111-8120 of 38457 for oral

1. Kristina A. Butler, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

   This study is to investigate the clinical usefulness of Gleolan (aminolevulinic acid hydrochloride, 5-ALA), an oral agent for the detection and visualization of ...

2. Comprehensive Stroke Measure - Mayo Clinic

   Patients receiving oral anticoagulants, as well as those with an acquired or congenital coagulopathy, are at increased risk for ICH and hemorrhagic ...

3. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

   In addition, oral corticosteroid treatment significantly alters the frequency and function of Breg subsets, which could lead altered clinical outcomes. Aims ...

4. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

5. Pathologists' Assistant Clinical Rotation (Florida) - Health Sciences Education

   Excellent written and oral communication skills. Non-U.S. citizen applicants. Admission to Mayo Clinic School of Health Sciences is open to U.S. workers in ...

6. Salivary gland tumors - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

7. MC1R-targeted Alpha-particle Monotherapy And Combination Therapy Trial With Nivolumab In Adults With Advanced Melanoma - Mayo Clinic

   * Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...

8. An Evaluation of the MitraClip System for treatment of Mitral Regurgitation in Heart Failure Patients - Mayo Clinic

   Chronic Obstructive Pulmonary Disease (COPD) requiring continuous home oxygen therapy or chronic outpatient oral steroid use. Untreated clinically ...

9. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

   Participation eligibility · Ability to swallow and retain oral tablets. · Women of childbearing potential and men must agree to use adequate contraception ( ...

10. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    If female and of childbearing potential, or if male, agree to use adequate contraception (e.g., abstinence, intrauterine device, oral contraceptive, or ...